EXtubation Related Complications - the EXTUBE Study (EXTUBE)
Launched by UNIVERSITY HEALTH NETWORK, TORONTO · Jun 3, 2024
Trial Information
Current as of February 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Globally, over 200 million people each year require extubation. While routinely performed, extubation is a skilled and potentially high-risk procedure that should be performed only when physiologic, pharmacologic, and contextual conditions are optimal. Complications at this stage of patient care can result in decreased oxygen delivery to the brain and body, sometimes leading to serious adverse events such as cardiac arrest, brain damage, or death. Indeed, one quarter of airway complications that result in death or brain death occur at the time of extubation.
Despite the frequency of extuba...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients (≥18 years old)
- • Undergoing extubation of an endotracheal tube (including index extubation and re-extubations) after general anesthesia in the OR, out of OR anesthesia location or ICU
- • Undergoing extubation during the specified enrollment window
- Exclusion Criteria:
- • Patients will be excluded if the extubation is performed in the context of withdrawal of life support measures,
- • Patients will be excluded if the extubation is performed for tracheostomy decannulation
- • For each patient who is not included, reasons for exclusion will be reported.
Trial Officials
Matteo Parotto, MD, PhD
Principal Investigator
UHN
About University Health Network, Toronto
University Health Network (UHN), based in Toronto, is a leading academic health sciences center dedicated to advancing patient care through innovative research and education. As a prominent sponsor of clinical trials, UHN integrates cutting-edge scientific discoveries with clinical practice, facilitating the development of new therapies and treatment modalities. With a commitment to improving health outcomes, UHN collaborates with a diverse network of researchers, healthcare professionals, and industry partners, fostering an environment that prioritizes patient safety and ethical standards in clinical research. Through its extensive resources and expertise, UHN plays a pivotal role in transforming healthcare and enhancing the quality of life for patients both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Toronto, Ontario, Canada
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0